Entering text into the input field will update the search result below

Blueprint Medicines EPS beats by $0.26, beats on revenue

Nov. 05, 2019 7:10 AM ETBlueprint Medicines Corporation (BPMC) StockBPMCBy: Niloofer Shaikh, SA News Editor
  • Blueprint Medicines  (NASDAQ:BPMC): Q3 GAAP EPS of -$1.93 beats by $0.26.
  • Revenue of $9.14M (+730.9% Y/Y) beats by $6.29M.
  • Press Release

Recommended For You

More Trending News

About BPMC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BPMC--
Blueprint Medicines Corporation